Sunday, September 14, 2025

PharmaCielo Struggles To Complete Financing, Extends Closing To March

It appears that PharmaCielo (TSXV: PCLO) is having a difficult time raising funds for its operations. The firm this morning announced further delays to the final closing of a financing announced in December.

The company is currently looking to raise $15.0 million from the sale of debenture units in a non-brokered offering. The units bear interest at a rate of 11% per annum, are valid for three years, and contain 250 common share purchase warrants. Warrants are valid for a period of 36 months, and contain a maturity of 50% over the offering price at the time of the initial closing. Debt under the offering is secured by the assets of the company.

Originally estimating to sell 15,000 units at $1,000 per each, the firm expected to close the offering on December 30, with proceeds being used for operations, working capital, and the build-out of its dry flower sales program.

However, the firm managed to close just $5.0 million in gross proceeds on December 31, which included a portion of insider participation.

The remaining portion of the financing however is now not expected to close until March 4, pending ongoing discussions with certain parties.

PharmaCielo last traded at $1.07 on the TSX Venture.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Soma Gold Q2 Earnings: Production Drops Amid Growth Effort

Guanajuato Q2 Earnings: Things Are Going Backwards

Electric Metals: The Sole US Domestic Source Of A Critical Mineral?

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Stifel Reinitiates Coverage On Eight Cannabis Operators

Earlier this week, Stifel released a new report on cannabis operations, focused predominantly on US-based...

Friday, July 24, 2020, 03:30:00 PM

PharmaCielo Records $0.4 Million In Revenue, $7.2 Million Net Loss In Q2 2021

PharmaCielo Ltd. (TSXV: PCLO) reported today its financial performance for the quarter ending June 30,...

Friday, August 20, 2021, 09:08:00 AM

Khiron Receives National Strategic Project Status From Colombian Government

This morning Khiron Life Sciences Corp (TSXV: KHRN) announced they received the status of National...

Tuesday, September 22, 2020, 09:43:55 AM

PharmaCielo Third Quarter Revenues Crater 97.9%, CEO Forced Out

PharmaCielo Ltd (TSXV: PCLO) this morning filed its third quarter financial results, posting brutal revenues...

Monday, November 30, 2020, 08:34:11 AM

PharmaCielo Receives Approval For US$3 Million Import Contract

PharmaCielo Ltd (TSXV: PCLO) has become one of the first venture listed equities to receive...

Friday, January 17, 2020, 09:02:20 AM